Bo Wang
Sun Yat-sen University
2 Papers
Bo Wang is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Fusobacterium nucleatum & Cyclin-dependent kinase 7. The author has an hindex of 2, co-authored 2 publications.
Chat about Author
Papers
The role of Fusobacterium nucleatum in colorectal cancer: from carcinogenesis to clinical management.
Chun-Hui Sun,Chun-Hui Sun,Bin-Bin Li,Bin-Bin Li,Bo Wang,Jing Zhao,Xiao-Ying Zhang,Ting-Ting Li,Wen-Bing Li,Di Tang,Miaojuan Qiu,Xin-Cheng Wang,Cheng-Ming Zhu,Zhi-Rong Qian +13 more
TL;DR: Findings indicated that an increased number of F. nucleatum in the tissues is a biomarker for the diagnosis and prognosis of CRC, and the underlying molecular mechanism can probably provide a potential intervention treatment strategy for patients with F.ucleatum-associated CRC.
105
Cyclin-dependent kinase 7 inhibitor THZ1 in cancer therapy.
Bin-Bin Li,Bin-Bin Li,Bo Wang,Cheng-Ming Zhu,Di Tang,Jun Pang,Zhao Jing,Chun-Hui Sun,Chun-Hui Sun,Qiu Miaojuan,Zhi-Rong Qian +10 more
TL;DR: This review summarized the current understanding with THZ1, a covalent inhibitor of cyclin-dependent kinase 7 (CDK7), which demonstrated promising anti-tumor activity against different cancer types.